16 completed. 16 Phase 2, 3 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 16 | Completed 16 |
| Phase 1 | 3 | Completed 3 |
| Phase 3 | 1 | Completed 1 |
Follow Somatoform Disorders: new trials by email Literature Review of Somatoform Disorders trials Research Report on Somatoform Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Watch and Wait and Surgical Treatment for Clinical Complete Responders After Non-Curative Therapy for Hepatocellular Carcinoma Liver Resection - Hepatocellular Carcinoma | Phase 2 | Completed | Sun Yat-sen University | 74 | 2022-05-05 | 2026-01-15 |
| Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder Psilocybin - Body Dysmorphic Disorders | Phase 2 | Completed | New York State Psychiatric Institute | 12 | 2021-02-26 | 2023-03-13 |
| Prevention of Taxane-associated Acute Pain Syndrome With Etoricoxib Etoricoxib - Pain Syndrome | Phase 2 | Completed | Guangdong Provincial People's Hospital | 144 | 2020-03-01 | 2022-02-14 |
| Effect of Cannabis and Endocannabinoids on HIV Neuropathic Pain Cannabis - Cannabis, HIV Neuropathy | Phase 2 | Completed | University of California, San Diego | 5 | 2018-07-01 | 2024-06-18 |
| Effects of Dry Needling on Neck and Shoulder Pain in Orchestral Musicians: a Prospective Case Series Deep dry needling - Pain Syndrome, Musculoskeletal Pain | Phase 1 / Phase 2 | Completed | CEU San Pablo University | 8 | 2018-02-01 | 2018-07-06 |
| A Trial of TD0019 in Treatment of Cervical Scapulohumeral Syndrome TD0019 oral capsule, Placebo oral capsule - Syndrome Pain | Phase 2 | Completed | Sao Thai Duong Joint Stock Company | 180 | 2017-08-30 | 2019-02-19 |
| Oxytocin Administration in BDD and OCD Oxytocin, Placebo - Body Dysmorphic Disorder, Obsessive-compulsive Disorder | Phase 2 | Completed | Massachusetts General Hospital | 41 | 2014-12-01 | 2018-11-23 |
| Imipramine Treatment for Patients With Multi-organ Bodily Distress Syndrome Imipramine treatment, Placebo - Somatisation Disorder, Somatoform Disorders | Phase 2 | Completed | University of Aarhus | 138 | 2012-01-01 | 2017-05-09 |
| Effects of Emotional Stimulation on the Stress Levels of Healthy Persons Emotional stimulation - Depression, Somatization Disorder | Phase 1 / Phase 2 | Completed | Charite University, Berlin, Germany | 21 | 2010-08-01 | 2010-10-25 |
| Internet-delivered Cognitive Behavioral Therapy (CBT) for Health Anxiety Internet-delivered CBT., On line discussion group - Hypochondriasis | Phase 2 | Completed | Karolinska Institutet | 80 | 2009-01-01 | 2015-05-06 |
| Treatment of Hypochondriasis With CBT and/or SSRI Fluoxetine, Cognitive Behavioral Therapy (CBT), Supportive Therapy - Hypochondriasis | Phase 1 / Phase 2 | Completed | Brigham and Women's Hospital | 195 | 2006-06-01 | 2017-04-25 |
| Treatment of Patients With Longstanding Unexplained Health Complaints Cognitive Behavioral Therapy, Recommendation of care (letter to general practitioner [GP]) - Somatization Disorder | Phase 2 / Phase 3 | Completed | University of Aarhus | 120 | 2005-04-01 | 2011-11-16 |
| Effectiveness of Cognitive-Affective Behavior Therapy for the Treatment of Somatization Disorder Augmented Standard Medical Care, Cognitive-Affective Behavior Therapy - Somatization Disorder | Phase 2 | Completed | Rutgers, The State University of New Jersey | 88 | 2003-08-01 | 2014-02-20 |
| A Study of CC-5013 in the Treatment of Complex Regional Pain Syndrome (CRPS) Lenalidomide - Complex Regional Pain Syndrome (RSD) | Phase 2 | Completed | Celgene Corporation | 40 | 2003-08-01 | 2008-01-03 |
| KATHY:Cognitive-behavioural Therapy for Hypochondriasis Cognitive behavioral psychotherapy - Hypochondriasis | Phase 2 | Completed | Copenhagen Trial Unit, Center for Clinical Intervention Research | 80 | 2001-12-01 | 2016-08-11 |
| Cognitive Behavior Therapy for Somatization Disorder Cognitive Behavior Therapy, Psychiatric Consultation Letter - Somatoform Disorders | Phase 2 | Completed | University of Medicine and Dentistry of New Jersey | 84 | 1999-09-01 | 2014-02-20 |
Hypochondriasis (3) · Body Dysmorphic Disorders (2) · Medically Unexplained Symptoms (2) · Anxiety Disorders (1) · Breast Neoplasms (1) · Carcinoma, Hepatocellular (1) · Complex Regional Pain Syndromes (1) · Conversion Disorder (1) · Depression (1) · Marijuana Abuse (1) · Musculoskeletal Pain (1) · Myofascial Pain Syndromes (1) · Neuralgia (1) · Obsessive-Compulsive Disorder (1)
Mental Disorders (16) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (5) · Behavior (3) · Nervous System Diseases (3) · Neurologic Manifestations (3) · Neuromuscular Diseases (3) · Neoplasms (2) · Neoplasms by Site (2) · Pain (2) · Peripheral Nervous System Diseases (2) · Adenocarcinoma (1) · Anxiety Disorders (1) · Autonomic Nervous System Diseases (1)
Cognitive Behavioral Therapy (3) · Etoricoxib (1) · Fluoxetine (1) · Hepatectomy (1) · Lenalidomide (1) · Oxytocin (1) · Palliative Care (1) · Psilocybin (1) · nabiximols (1) · olanzapine-fluoxetine combination (1)
University of Aarhus (2) · Brigham and Women's Hospital (1) · CEU San Pablo University (1) · Celgene Corporation (1) · Charite University, Berlin, Germany (1) · Copenhagen Trial Unit, Center for Clinical Intervention Research (1) · Guangdong Provincial People's Hospital (1) · Karolinska Institutet (1) · Massachusetts General Hospital (1) · New York State Psychiatric Institute (1) · Rutgers, The State University of New Jersey (1) · Sao Thai Duong Joint Stock Company (1) · Sun Yat-sen University (1) · University of California, San Diego (1) · University of Medicine and Dentistry of New Jersey (1)
United States (7) · China (2) · Denmark (2) · Germany (1) · Spain (1) · Sweden (1) · Vietnam (1)
Lesley A. Allen, PhD (2) · Angela Fang, Ph.D. (1) · Arthur J. Barsky, MD (1) · Brian Fallon, MD (1) · Brook L Henry, PhD (1) · Donald Manning, MD, PhD (1) · Franklin Schneier, MD (1) · Kun Wang, MD (1) · Morten Birket-Smith, DMSc (1) · Per Fink, Dr.Med.Sc. (1) · Per Sorensen, MD (1)
PMID 21357882, PMID 22539780, PMID 22608115, PMID 25437150, PMID 26785798, PMID 28408193, PMID 28659038, PMID 35724467, PMID 40458078
K08MH001662 (1), R01MH071688 (1), R21MH066831 (1)